Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lillian Cohn

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Frontiers in Immunology|June 10, 2014
Dendritic cell-targeted vaccinesLillian Cohn, Lélia Delamarre
Plos Pathogens|March 14, 2012
Influenza A virus infection of human primary dendritic cells impairs their ability to cross-present antigen to CD8 T cellsAnna Smed-Sörensen, Cécile Chalouni, Bithi Chatterjee, et al.
Journal of Clinical Immunology|June 30, 2009
siRNA knockdown of PD-L1 and PD-L2 in monocyte-derived dendritic cells only modestly improves proliferative responses to Gag by CD8(+) T cells from HIV-1-infected individualsGaëlle Breton, Bader Yassine-Diab, Lillian Cohn, et al.
Blood|July 14, 2012
Internalization and endosomal degradation of receptor-bound antigens regulate the efficiency of cross presentation by human dendritic cellsBithi Chatterjee, Anna Smed-Sörensen, Lillian Cohn, et al.
Social Science & Medicine (1982)|January 4, 2025
Evaluating the psychosocial experiences of participants in HIV cure research before, during, and after analytical treatment interruptions: A longitudinal qualitative study in the United StatesMiranda Hill, Lidia Rodriguez Garcia, Elizabeth Nguyen, et al.
The Journal of Experimental Medicine|April 10, 2013
Antigen delivery to early endosomes eliminates the superiority of human blood BDCA3+ dendritic cells at cross presentationLillian Cohn, Bithi Chatterjee, Filipp Esselborn, et al.
Biorxiv : the Preprint Server for Biology|January 7, 2025
Inflammatory Monocytes Increase Prior to Detectable HIV-1 Rebound ViremiaAnna Farrell-Sherman, Natalia de la Force, Cecila Prator, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Frontiers in Immunology|June 10, 2014
Dendritic cell-targeted vaccinesLillian Cohn, Lélia Delamarre
Plos Pathogens|March 14, 2012
Influenza A virus infection of human primary dendritic cells impairs their ability to cross-present antigen to CD8 T cellsAnna Smed-Sörensen, Cécile Chalouni, Bithi Chatterjee, et al.
Journal of Clinical Immunology|June 30, 2009
siRNA knockdown of PD-L1 and PD-L2 in monocyte-derived dendritic cells only modestly improves proliferative responses to Gag by CD8(+) T cells from HIV-1-infected individualsGaëlle Breton, Bader Yassine-Diab, Lillian Cohn, et al.
Blood|July 14, 2012
Internalization and endosomal degradation of receptor-bound antigens regulate the efficiency of cross presentation by human dendritic cellsBithi Chatterjee, Anna Smed-Sörensen, Lillian Cohn, et al.
Social Science & Medicine (1982)|January 4, 2025
Evaluating the psychosocial experiences of participants in HIV cure research before, during, and after analytical treatment interruptions: A longitudinal qualitative study in the United StatesMiranda Hill, Lidia Rodriguez Garcia, Elizabeth Nguyen, et al.
The Journal of Experimental Medicine|April 10, 2013
Antigen delivery to early endosomes eliminates the superiority of human blood BDCA3+ dendritic cells at cross presentationLillian Cohn, Bithi Chatterjee, Filipp Esselborn, et al.
Biorxiv : the Preprint Server for Biology|January 7, 2025
Inflammatory Monocytes Increase Prior to Detectable HIV-1 Rebound ViremiaAnna Farrell-Sherman, Natalia de la Force, Cecila Prator, et al.
Pageof 1